Clinical Trials Directory

Trials / Completed

CompletedNCT01756274

Evaluation of Blood Glucose Monitoring Systems With Blood Samples From Neonates

Performance of Three Bayer Blood Glucose Monitoring Systems With Blood Samples From Neonates

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
162 (actual)
Sponsor
Ascensia Diabetes Care · Industry
Sex
All
Age
30 Days
Healthy volunteers
Accepted

Summary

The purpose of this study was to evaluate the performance of three Bayer Blood Glucose Monitoring Systems (BGMS) with neonatal blood. Blood samples used in this study were 'left-over samples'. The blood samples were from heel sticks of neonates, collected (into a tube) and sent to the laboratory. All meter Blood Glucose (BG) results were compared with capillary plasma results obtained with a reference laboratory glucose method (Cobas® 6000 instrument).

Conditions

Interventions

TypeNameDescription
DEVICEContour® NEXT BGMSLab professionals tested the BG concentration using Contour® NEXT BGMS (Blood Glucose Monitoring System). All meter BG results were compared with capillary plasma results obtained with a reference laboratory glucose method, Cobas® 6000 instrument (Roche Diagnostics Corp., Indianapolis, IN).
DEVICEContour® PLUS BGMSLab professionals tested the BG concentration using Contour® PLUS BGMS (Blood Glucose Monitoring System). All meter BG results were compared with capillary plasma results obtained with a reference laboratory glucose method, Cobas® 6000 instrument (Roche Diagnostics Corp., Indianapolis, IN).
DEVICEContour® Next EZ BGMSLab professionals tested the BG concentration using Contour® Next EZ BGMS (Blood Glucose Monitoring System). All meter BG results were compared with plasma results obtained with a reference laboratory glucose method, Cobas® 6000 instrument (Roche Diagnostics Corp., Indianapolis, IN).

Timeline

Start date
2012-12-01
Primary completion
2013-02-01
Completion
2013-02-01
First posted
2012-12-25
Last updated
2017-02-15
Results posted
2014-04-09

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01756274. Inclusion in this directory is not an endorsement.